TD-1607

N/A

Report date: 2022/07/04 19:38:02

NME

Base Information

Drug NameTD-1607

Drug Alias NameTD-1607

ClassificationSmall molecules > Synthetic peptideSmall molecules > Heterocyclic drugs > AntibioticsSmall molecules > Heterocyclic drugs > Antibiotics > β-lactam antibiotics > Cephalosporins antibiotics +[4]

Mechanisms of ActionCell wall inhibitorsPeptidoglycan inhibitorsBacterial penicillin-binding protein inhibitors

TargetsPeptidoglycanBacterial penicillin-binding protein

Therapy Area/IndicationsGram-Positive Bacterial InfectionsBacterial InfectionsInfections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesTheravance Biopharma Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesTheravance Biopharma Inc

Active IndicationsN/A

Inactive IndicationsGram-Positive Bacterial InfectionsBacterial InfectionsInfections

Other Information

ATC CodeN/A